Case Based Discussion: Role of Genetic Testing and End of Life Care

Role of Genetic Testing in Advanced M1 CRPC & M1 CPRC Post-docetaxel, Neuroendocrine Cancer and End of Life Care Presented by Leonard Gomella, MD and Joshua Lang, MD https://auau.auanet.org/node/34071 Acknowledgements Support provided by independent educational grants from: Amgen Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Exact Sciences Corporation Merck Pfizer, Inc. Sanofi Genzyme